Renaissance Technologies’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $414K | Buy |
167,100
+87,200
| +109% | +$216K | ﹤0.01% | 2928 |
|
|
2025
Q1 | $124K | Sell |
79,900
-824,100
| -91% | -$1.28M | ﹤0.01% | 3158 |
|
|
2024
Q4 | $1.93M | Buy |
904,000
+650,200
| +256% | +$1.39M | ﹤0.01% | 2074 |
|
|
2024
Q3 | $1.1M | Sell |
253,800
-10,100
| -4% | -$43.9K | ﹤0.01% | 2380 |
|
|
2024
Q2 | $1.23M | Buy |
263,900
+51,300
| +24% | +$239K | ﹤0.01% | 2204 |
|
|
2024
Q1 | $1.08M | Sell |
212,600
-237,800
| -53% | -$1.21M | ﹤0.01% | 2440 |
|
|
2023
Q4 | $1.27M | Buy |
450,400
+121,500
| +37% | +$342K | ﹤0.01% | 2245 |
|
|
2023
Q3 | $944K | Buy |
328,900
+108,200
| +49% | +$311K | ﹤0.01% | 2352 |
|
|
2023
Q2 | $1.12M | Buy |
220,700
+3,200
| +1% | +$16.2K | ﹤0.01% | 2405 |
|
|
2023
Q1 | $411K | Sell |
217,500
-3,113
| -1% | -$5.88K | ﹤0.01% | 2981 |
|
|
2022
Q4 | $397K | Buy |
220,613
+2,913
| +1% | +$5.24K | ﹤0.01% | 3086 |
|
|
2022
Q3 | $368K | Sell |
217,700
-54,302
| -20% | -$91.8K | ﹤0.01% | 3099 |
|
|
2022
Q2 | $669K | Buy |
272,002
+7,511
| +3% | +$18.5K | ﹤0.01% | 2973 |
|
|
2022
Q1 | $733K | Sell |
264,491
-120,909
| -31% | -$335K | ﹤0.01% | 2932 |
|
|
2021
Q4 | $2.05M | Buy |
+385,400
| New | +$2.05M | ﹤0.01% | 2119 |
|
|
2021
Q2 | – | Sell |
-18,600
| Closed | -$451K | – | 3455 |
|
|
2021
Q1 | $451K | Buy |
+18,600
| New | +$451K | ﹤0.01% | 2942 |
|
|
2020
Q3 | – | Sell |
-26,507
| Closed | -$1.12M | – | 3376 |
|
|
2020
Q2 | $1.12M | Buy |
+26,507
| New | +$1.12M | ﹤0.01% | 2490 |
|